Filter Results
Management of dyskinesia in Parkinson's disease
Rajesh Pahwa (University of Kansas Medical Center) discusses the management of dyskinesia in Parkinson's disease with a focus on amantadine (GOCOVRI™), the first and only FDA-approved medication for this indication.
Expert perspective on Parkinson's disease
Werner Poewe (Medical University Innsbruck, Austria), a recent welcome addition to our editorial board for European Neurological Review, shares his insights and highlights on Parkinson's disease from the American Academy of Neurology (AAN) Annual Meeting 2018.
Latest developments in the management of Parkinson's disease
Latest developments in the management of Parkinson's disease
